Skip to main content
Fig. 1 | Arthritis Research & Therapy

Fig. 1

From: Antiphospholipid antibodies as potential predictors of disease severity and poor prognosis in systemic lupus erythematosus-associated thrombocytopenia: results from a real-world CSTAR cohort study

Fig. 1

Flow chart of patient selection. A total of 408 SLE patients with thrombocytopenia (SLE-TP) in the Chinese SLE Treatment and Research Group(CSTAR). Six thrombocytopenia patients were caused by other reasons. 28 were lost during follow-up and 24 had incomplete data. 350 SLE-TP with complete platelet follow-up data were included in this cohort, of whom 156 without any positive aPLs. Among 194 SLE-TP with aPLs, 75 had single kind aPL, 51 had double aPLs, and 68 had triple aPLs

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us